CIK 0001620463 · Non-accelerated filer<br>Smaller reporting company
LeonaBio, Inc.
Sign in to watch- Ticker
- LONA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 453368487
- Phone
- (425) 620-8501
- Business address
- 18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL, WA, 98011
- Former names
- Athira Pharma, Inc., M3 Biotechnology, Inc.
- Open-market buys, last 90 days
- $9,919,161,281
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,919,161,281. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 85 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-07-01 | Renninger Robert SVP, Finance and Accounting | Sale | −2,897 | $0.29 | $850 | 109,186 |
| 2025-06-30 | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | Option exercise | +36,666 | 177,427 | ||
| 2025-06-30 | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | Option exercise · Restricted Stock Units | −36,666 | 36,667 | ||
| 2025-06-30 | Litton Mark James President and CEO | Option exercise | +108,334 | 350,925 | ||
| 2025-06-30 | Litton Mark James President and CEO | Option exercise · Restricted Stock Units | −108,334 | 108,333 | ||
| 2025-06-30 | San Martin Javier CHIEF MEDICAL OFFICER | Option exercise | +46,666 | 82,507 | ||
| 2025-06-30 | San Martin Javier CHIEF MEDICAL OFFICER | Option exercise · Restricted Stock Units | −46,666 | 46,667 | ||
| 2025-06-30 | Worthington Mark General Counsel and CCO | Option exercise | +36,666 | 120,401 | ||
| 2025-06-30 | Worthington Mark General Counsel and CCO | Option exercise · Restricted Stock Units | −36,666 | 36,667 | ||
| 2025-06-30 | Renninger Robert SVP, Finance and Accounting | Option exercise | +12,359 | 112,083 | ||
| 2025-06-30 | Renninger Robert SVP, Finance and Accounting | Option exercise · Restricted Stock Units | −12,359 | 12,359 | ||
| 2025-05-30 | FLUKE JOHN M JR Director | Grant or award · Stock Option (Right to Buy) | +20,900 | 20,900 | ||
| 2025-05-30 | Panzara Michael A. Director | Grant or award · Stock Option (Right to Buy) | +20,900 | 20,900 | ||
| 2025-05-30 | Romano Kelly A Director | Grant or award · Stock Option (Right to Buy) | +20,900 | 20,900 | ||
| 2025-05-30 | EDELMAN JOSEPH Director | Grant or award · Stock Option (Right to Buy) | +20,900 | 20,900 | ||
| 2025-05-30 | JOHNSON JAMES A Director | Grant or award · Stock Option (Right to Buy) | +20,900 | 20,900 | ||
| 2025-05-30 | Kosacz Barbara Director | Grant or award · Stock Option (Right to Buy) | +20,900 | 20,900 | ||
| 2025-05-30 | PICKERING GRANT Director | Grant or award · Stock Option (Right to Buy) | +20,900 | 20,900 | ||
| 2025-05-19 | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | Grant or award | +10,000 | $0.23 | $2K | 140,761 |
| 2025-05-19 | Renninger Robert SVP, Finance and Accounting | Grant or award | +10,000 | $0.23 | $2K | 99,724 |
Page 5 of 10 · 187 trades